From:  Insulin pump therapy and continuous glucose monitoring in adults with type 2 diabetes: where are we now?
 

Pros and cons of CSII and CGM technology among subjects with T2D

ProsCons
Both for CSII and CGMImprovement of HbA1c level in short and long-termOnly for selected patients suitable for technology
Necessity of time for specific training
Need for healthcare provider team trained to technology use
Usually discrete and easy to wear
Improved quality of life
Useful and effective in case of pregnancy and its planning		Risk of skin reactions at the insertion site
Risk of non-adherence or early discontinuation of technology use
Short term* cost and its coverage
CGM specific issuesReduction of hypoglycemic events
Complete glucose profiles
No calibration needed for some devices		Risk of long term burn-out by alarms
Big amount of data to be interpreted
Calibration needed for some devices
CSII specific issuesTailored insulin therapy
Efficacy both in obese and in non-obese patients
Return to article view

long term cost must be evaluated in cost effectiveness studies, to evaluate if long term reduction of diabetes related complications could compensate initial costs